American Century Companies’s Janux Therapeutics JANX Stock Holding History

American Century Companies's JANX Position: Q1 2026 in Review

American Century Companies increased its Janux Therapeutics (JANX) stake by 9.1% in Q1 2026, buying an estimated $34.6K and bringing the position to 30,215 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #2561.

American Century Companies first reported a position in JANX in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.02M in Q1 2024. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

• American Century Companies held 30,215 shares of Janux Therapeutics worth $420K as of Q1 2026.
• American Century Companies bought 2,524 Janux Therapeutics shares in Q1 2026, an estimated $34.6K.
• Janux Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2561 holding.
• American Century Companies first reported a position in Janux Therapeutics in Q4 2023 and has held it in 7 quarters since.
• American Century Companies's Janux Therapeutics position peaked at $1.02M in Q1 2024.
• 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.